These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2902937

  • 1. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B, Naden MG.
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [Abstract] [Full Text] [Related]

  • 2. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B, Naden MG.
    J Chemother; 1989 Jul; 1(4 Suppl):106-7. PubMed ID: 16312326
    [No Abstract] [Full Text] [Related]

  • 3. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984 Jun; 43():44-9. PubMed ID: 6100139
    [Abstract] [Full Text] [Related]

  • 5. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D, Douboyas J, Papapanagiotou J, Paradelis AG.
    Methods Find Exp Clin Pharmacol; 1982 Jun; 4(3):173-7. PubMed ID: 7121128
    [Abstract] [Full Text] [Related]

  • 7. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K, Chong Y, Jeong SH, Xu XS, Kwon OH.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [Abstract] [Full Text] [Related]

  • 8. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ, Thibault M, Duval J.
    Nouv Presse Med; 1981 Feb 26; 10(8):556-8. PubMed ID: 6259592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ, Deforges L, Le Van Thoi J, Chanal M, Sirot D, Acar JF, Kitzis MD, Thabaut A, Meyran M, Dabernat H.
    Pathol Biol (Paris); 1985 Jun 26; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group.
    Snydman DR, Jacobus NV, McDermott LA.
    J Antimicrob Chemother; 2005 Jun 26; 55(6):1024-8. PubMed ID: 15824092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP, Pottumarthy S, Morris AJ.
    N Z Med J; 1999 Nov 12; 112(1099):424-6. PubMed ID: 10678225
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
    Aldridge KE, Johnson WD.
    J Antimicrob Chemother; 1997 Mar 12; 39(3):319-24. PubMed ID: 9096180
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM, Gille Y, Marcel JP, Vincent P.
    Sem Hop; 1997 Mar 12; 56(43-44):1793-5. PubMed ID: 6256880
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.